Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

8.36
-0.2650-3.07%
Volume:51.06K
Turnover:434.28K
Market Cap:19.10M
PE:-0.53
High:8.73
Open:8.37
Low:8.35
Close:8.63
52wk High:44.00
52wk Low:3.02
Shares:2.29M
Float Shares:694.50K
Volume Ratio:3.01
T/O Rate:7.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:1.03
PE(LYR):-0.41

Loading ...

Akari Therapeutics Raises CEO Abizer Gaslightwala Base Salary to $625,000

Reuters
·
Oct 02

Akari Therapeutics expands IP portfolio with PCT filing for ADC payload

TIPRANKS
·
Oct 01

Akari Therapeutics Files PCT Patent Application for PH1 RNA-Splicing ADC Payload in Cancer

Reuters
·
Oct 01

Akari Therapeutics Expands Intellectual Property Portfolio with Pct Filing for ADC Payload Related to Rna Splicing in Cancers

THOMSON REUTERS
·
Oct 01

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week

MT Newswires Live
·
Sep 25

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

MT Newswires Live
·
Sep 10

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Sep 09

European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live
·
Sep 08

Akari Therapeutics to Present PH1 ADC Payload Platform at Oncology and Investor Conferences

Reuters
·
Sep 08

European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading

MT Newswires Live
·
Aug 31

Akari Therapeutics Participates in Virtual Investor “Why Now” On-Demand Conference Webcast

Reuters
·
Aug 27

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Aug 26

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Akari Therapeutics - Ph1 Payload Shows Potential to Overcome Payload-Specific Resistance

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity in Urothelial Cancer Preclinical Models

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Continues to Advance Ind-Enabling Activities for Aktx-101 with Goal of Initiating Phase 1 Clinical Trial in Mid-2027

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Developing Aktx-102 ADC Targeting Ceacam5 in Multiple Solid Tumors

THOMSON REUTERS
·
Aug 18

Akari Therapeutics Says AKTX-101 Shows Anti-Tumor Activity in Preclinical Urothelial Cancer Models

Reuters
·
Aug 18